J.B.CHEMICALS & PHARMACEUTICALS LTD.

JB Chemicals & Pharmaceuticals Ltd has announced the effective date of its amalgamation with Torrent Pharmaceuticals Limited. Following the approval and sanction from the National Company Law Tribunal (NCLT), Ahmedabad Bench, the certified copy of the order was filed with the Registrar of Companies on July 8, 2026. Consequently, the scheme of amalgamation is now effective as of July 8, 2026. JB Chemicals stands amalgamated into and with Torrent Pharma and is dissolved without being wound up. The appointed date for the amalgamation is January 21, 2026.

JB Chemicals & Pharmaceuticals Ltd. has announced Friday, July 17, 2026, as the Record Date for its Scheme of Amalgamation with Torrent Pharmaceuticals Limited. This follows the sanctioning of the scheme by the Hon'ble National Company Law Tribunal, Ahmedabad Bench, on July 6, 2026. The Record Date is set to determine the JB Chemicals shareholders who will be entitled to receive fully paid-up equity shares of Torrent Pharma. The approved share exchange ratio is 51 fully paid-up equity shares of Torrent Pharma (face value ₹5 each) for every 100 fully paid-up equity shares of JB Chemicals (face value ₹1 each).

JB Chemicals & Pharmaceuticals Ltd has received the certified true copy of the Order passed by the National Company Law Tribunal (NCLT), Ahmedabad Bench, sanctioning the Scheme of Amalgamation. This scheme involves the amalgamation of J. B. Chemicals & Pharmaceuticals Limited (Transferor Company) with Torrent Pharmaceuticals Limited (Transferee Company) and their respective shareholders. The NCLT's order was dated July 6, 2026, and the company received the certified copy on July 7, 2026. The details of the sanctioned scheme are available on the company's website.

JB Chemicals & Pharmaceuticals Ltd announced that the National Company Law Tribunal (NCLT), Ahmedabad Bench, has sanctioned the Scheme of Amalgamation of JB Chemicals & Pharmaceuticals Limited with Torrent Pharmaceuticals Limited. The order was pronounced on July 6, 2026. The amalgamation will become effective upon filing the certified copy of the NCLT order with the Registrar of Companies. The company will inform the stock exchanges once the scheme is effective.

JB Chemicals & Pharmaceuticals Ltd has announced the closure of its trading window for dealing in the company's securities. This closure will be effective from July 1, 2026, and will remain in effect until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, aimed at preventing potential insider trading activities around the financial results announcement.

JB Chemicals & Pharmaceuticals Ltd has announced the retirement of two key senior management personnel: Mr. Pradeep Kumar Singh, President Global Business, and Mr. Suresh Bhise, Vice President – IT. Both individuals will cease to be Senior Management Personnel effective from the close of business hours on June 30, 2026. This disclosure is made in accordance with SEBI's Listing Obligations and Disclosure Requirements Regulations.

JB Chemicals & Pharmaceuticals Ltd announced the cessation of Mr. Bhushan Sachdev as the Executive Vice President – Supply Chain Management. His resignation is effective from the closing of business hours on June 12, 2026, citing personal reasons. This disclosure was made under Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, following a request from BSE Limited for a fresh corporate announcement regarding his departure.

JB Chemicals & Pharmaceuticals Ltd announced the resignation of Mr. Bhushan Sachdev from his position as Executive Vice President – Supply Chain Management. His cessation is effective from the closing of business hours on June 12, 2026. The company has provided the necessary disclosures as per SEBI regulations regarding the reason for change and the effective date.

JB Chemicals & Pharmaceuticals Ltd dispatched letters with web-links to access the Integrated Annual Report for FY 2025-26 to shareholders who haven't registered their email addresses with the Registrar & Share Transfer Agent or Depository Participants. The 50th Annual General Meeting (AGM) is scheduled for June 17, 2026, via Video Conference. The AGM notice and Integrated Annual Report have been sent electronically to members with registered email addresses.

JB Chemicals & Pharmaceuticals Ltd has released its Integrated Annual Report for the fiscal year 2025-26, in compliance with SEBI regulations. The report, along with the notice for the Annual General Meeting scheduled for June 17, 2026, will be sent to the company's shareholders. The annual report highlights the company's legacy, sustainable growth, financial performance, and strategic focus on strengthening its domestic franchise and expanding its international presence. JB Pharma has a presence in 40+ countries with 8 manufacturing facilities.